Related Experiment Video
Updated: Jan 18, 2026

09:09
Preparation of Neutrally-charged, pH-responsive Polymeric Nanoparticles for Cytosolic siRNA Delivery
Published on: May 2, 2019
7.9K
Tuning pH for the Controlled Formation of Ultrasmall Nanoparticles with Direct Cytosolic Access
Linqing Tian1, Qiaoyun Wang1, Ramindu De Silva1
1School of Chemistry, University of New South Wales, Sydney, NSW, 2052, Australia.
Angewandte Chemie (International Ed. in English)
|January 16, 2026
Summary
Researchers developed a pH-tunable polymer system for creating ultrasmall nanoparticles (USNPs) for direct drug delivery to the cell cytosol. This platform overcomes challenges in drug loading and intracellular trafficking for enhanced therapeutic applications.
Area of Science:
- Biotechnology
- Materials Science
- Nanomedicine
Background:
- Direct cytosolic delivery of nanoparticles bypasses endocytic pathways, reducing intracellular trafficking barriers.
- Ultrasmall nanoparticles (<10 nm) offer potential for membrane translocation but face drug loading and stability challenges.
Purpose of the Study:
- To develop a versatile polymer system for producing ultrasmall nanoparticles (USNPs) for direct drug delivery.
- To overcome limitations of current USNP technologies regarding drug loading and stability.
Main Methods:
- A pH-tunable polymer system was employed to generate nanoparticles (10-50 nm) with subsequent crosslinking for stability.
- Machine learning and molecular dynamics (MD) simulations were used to correlate drug properties (e.g., pKaH) with encapsulation and nanoparticle size.
- Experimental validation confirmed direct cytosolic delivery and bypassing of the endosomal pathway.
Main Results:
- The polymer system successfully encapsulated diverse drugs into stable nanoparticles by adjusting pH.
- Machine learning identified drug pKaH as a critical factor for encapsulation efficiency.
- MD simulations revealed USNP surface properties conducive to cell membrane interaction.
- Experimental data confirmed direct cytosolic delivery of the synthesized USNPs.
Conclusions:
- The developed platform enables facile production of ultrasmall nanoparticles for a wide range of drugs.
- This strategy provides a robust method for improved intracellular drug delivery via direct cytosolic entry.
- The findings offer a promising approach for advancing nanomedicine and drug delivery systems.

